What is the recommended treatment for bacterial meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bacterial Meningitis Treatment

Immediate Empiric Antibiotic Therapy

Begin treatment within 1 hour of presentation with a third-generation cephalosporin plus vancomycin, adding ampicillin for patients over 50 years or those with risk factors for Listeria monocytogenes. 1, 2, 3

Age-Based Empiric Regimens

Neonates (<1 month):

  • Ampicillin 50 mg/kg IV every 6-8 hours PLUS cefotaxime 50 mg/kg IV every 6-8 hours 2, 3
  • Alternative: Ampicillin plus gentamicin 2.5 mg/kg IV every 8-12 hours (age-dependent) 2

Children (1 month to 18 years):

  • Ceftriaxone 50 mg/kg IV every 12 hours (maximum 2g every 12 hours) OR cefotaxime 75 mg/kg IV every 6-8 hours 1, 2
  • PLUS vancomycin 10-15 mg/kg IV every 6 hours (target trough 15-20 mg/mL) 2

Adults (18-50 years):

  • Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 4-6 hours 1, 2
  • PLUS vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mg/mL) 1, 2

Adults (>50 years or immunocompromised):

  • Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 4-6 hours 1, 2
  • PLUS vancomycin 15-20 mg/kg IV every 8-12 hours 1, 2
  • PLUS ampicillin 2g IV every 4 hours (for Listeria coverage) 1, 2, 3

Adjunctive Dexamethasone Therapy

Administer dexamethasone 10 mg IV every 6 hours (0.15 mg/kg every 6 hours in children) 10-20 minutes before or simultaneously with the first antibiotic dose. 1, 2, 3

  • Continue for 4 days if pneumococcal or H. influenzae meningitis is confirmed 1, 2
  • Discontinue if another pathogen is identified 1
  • In adults with pneumococcal meningitis, dexamethasone reduces unfavorable outcomes (26% vs 52%, P=0.006) and mortality (14% vs 34%, P=0.02) 2

Critical Caveat on Dexamethasone

Dexamethasone may reduce CSF penetration of vancomycin—when treating suspected resistant pneumococci with dexamethasone, consider adding rifampin to the regimen. 1

Pathogen-Specific Definitive Therapy (After Culture Results)

Streptococcus pneumoniae:

  • Penicillin MIC <0.1 μg/mL: Switch to penicillin G 24 million units/day (divided every 4 hours) OR ampicillin 1, 2
  • Penicillin MIC 0.1-1.0 μg/mL: Continue third-generation cephalosporin 1
  • Penicillin MIC ≥2.0 μg/mL OR ceftriaxone MIC ≥1.0 μg/mL: Continue vancomycin PLUS third-generation cephalosporin 1
  • Duration: 10-14 days 1, 2

Neisseria meningitidis:

  • Penicillin-susceptible: Switch to penicillin G 24 million units/day OR continue ceftriaxone 2g every 12 hours 1, 2
  • Reduced susceptibility: Continue third-generation cephalosporin 1
  • Duration: 5-7 days 1, 2
  • Give single dose ciprofloxacin 500mg PO for eradication 3

Haemophilus influenzae:

  • β-lactamase negative: Switch to ampicillin 1
  • β-lactamase positive: Continue third-generation cephalosporin 1
  • Duration: 10 days 2

Listeria monocytogenes:

  • Ampicillin 2g IV every 4 hours (12g total daily dose) 2, 3
  • Duration: 21 days 2

Culture-negative meningitis:

  • Continue empiric regimen for at least 14 days 1

Critical Timing and Diagnostic Considerations

Do not delay antibiotics for imaging or lumbar puncture—start treatment within 1 hour even if CT or LP is pending. 1, 2, 3

  • Obtain blood cultures before antibiotics, but do not delay treatment beyond 1 hour 3
  • If lumbar puncture is delayed, start empiric treatment immediately on clinical suspicion 3
  • CSF findings (elevated WBC, decreased glucose, elevated protein) remain diagnostically useful even after antibiotics are started 3

Indications for CT Before Lumbar Puncture

Perform CT before LP if patient has: 3

  • Age ≥60 years
  • Immunocompromise
  • History of CNS disease (mass lesion, stroke, focal infection)
  • New-onset seizures
  • Altered mental status or GCS ≤12
  • Focal neurological deficits
  • Papilledema

Critical Care Considerations

Transfer to ICU if patient has: 1, 3

  • Rapidly evolving rash or limb ischemia
  • GCS ≤12 (or drop >2 points)
  • Cardiovascular instability or acid/base disturbance
  • Hypoxia or respiratory compromise
  • Frequent or uncontrolled seizures
  • Requirement for monitoring or specific organ support

Strongly consider intubation if GCS <12. 1, 3

Common Pitfalls to Avoid

Never use vancomycin as monotherapy for bacterial meningitis, even for highly resistant pneumococcal strains. 1

Never use rifampin as monotherapy due to rapid development of resistance. 1

Never fail to cover Listeria in patients >50 years or immunocompromised—this requires ampicillin addition. 2, 3

Never delay antibiotics for imaging—delayed treatment is strongly associated with death and poor neurological outcomes. 1, 3

Never use suboptimal antibiotic doses that don't achieve adequate CSF penetration. 3

Dosing Adjustments for Renal Impairment (Adults)

Creatinine clearance >50 mL/min: Standard dosing every 8 hours 1

Creatinine clearance 26-50 mL/min: Standard dose every 12 hours 1

Creatinine clearance 10-25 mL/min: Half the standard dose every 12 hours 1

Creatinine clearance <10 mL/min: Half the standard dose every 24 hours 1

References

Guideline

Bacterial Meningitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial Meningitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.